Report / Paper metadata
Tembusu virus neuroinvasion and neuropathogenesis: lessons from blood–brain barrier dysfunction in neurotropic flaviviruses
This review organizes what is known about how Tembusu virus might reach and damage the central nervous system by comparing better-studied flaviviruses. Its stage-based framework is a way to structure open questions: the route this virus uses to enter the brain, and where blood-brain barrier dysfunction fits, remain unresolved.
What is Tembusu virus?
Tembusu virus is a mosquito-borne flavivirus best known for outbreaks in farmed ducks and geese, where it caused egg-drop and systemic disease. It has continued to diversify into multiple genetic clusters and has been detected in chickens, house sparrows and mosquitoes, though the strength of evidence for host or vector roles differs across species. This review concerns an animal-health pathogen; it does not establish infection or disease risk in people.
What evidence shows brain involvement?
Studies report neurological signs, brain lesions, nonsuppurative encephalitis, and viral RNA or antigen in brain tissue in infected birds and in experimental mammalian models. The review is careful about what this proves: detecting virus in the brain establishes central nervous system involvement, but not the route of entry, the infected cell types, or how injury follows. Some newer lineages show stronger brain-associated disease than early epidemic strains, yet whether that reflects easier entry, faster brain replication or a stronger host inflammatory response is unknown.
What does the key timing study show?
The strongest virus-specific evidence comes from a duckling study in which viral particles were detected in brain tissue before obvious clinical signs or measurable increases in barrier permeability. Marked barrier disruption and inflammatory cytokine accumulation appeared later. In that model, brain infection preceded overt barrier breakdown, supporting barrier injury as a downstream event. Whether this sequence holds across other strains, host species, ages or infection routes remains untested.
What are the three proposed barrier roles?
The review frames blood-brain barrier dysfunction as a possible facilitator of viral entry, a consequence of established brain infection, or an amplifier of later neuroinflammatory injury. These are candidate roles drawn largely from other flaviviruses, not mechanisms demonstrated for Tembusu virus, and they are not mutually exclusive within one infection. The authors state current evidence is insufficient to define a dominant barrier-impairment mode across lineages, hosts or infection conditions.
How strong is the genetic evidence?
Variation in the envelope protein is a plausible driver of differences in brain-associated disease because that protein governs attachment, fusion and cell tropism. But associations between sequence changes and disease phenotypes remain descriptive until tested by reverse genetics under matched conditions. Proposed roles for nonstructural proteins come mainly from other flaviviruses; direct evidence linking them to Tembusu virus brain disease is limited. Higher brain viral load alone cannot show which disease step a mutation affects.
How should the animal models be read?
Mice show strong disease after direct brain inoculation but limited or inconsistent infection after peripheral routes. Direct inoculation bypasses the entry step, so it tests post-entry replication and neurovirulence rather than natural neuroinvasion; avian models preserve the full peripheral-to-brain sequence. Mechanisms from Japanese encephalitis, West Nile, Zika, dengue and tick-borne encephalitis viruses are comparative reference points, not templates. This narrative review reports no new experiments of its own.
- Kind
- Paper metadata
- Identifier
- PMC13643912